Partnerships

Precision Medicine - Biomarkers & Diagnostics

Acobiom, a remarkable experience in international R&D collaborations

Acobiom is or has been involved in several national and international research programs focused on the discovery of biomarkers, on the development of innovative diagnostics and therapeutics.

R-LiNK
(2018-2022)
European / H2020 grants

Optimizing response to Lithium treatment through personalized evaluation of individuals with bipolar I disorder.

Coordination: Frank Bellivier’s team (AP-HP, Paris, France).

ONCOSNIPE
(2017-2020)
Bpifrance funds

Development of tools of diagnostic and of the research of new therapeutic targets for patients resistant to cancer treatments.

Coordination: Oncodesign (France).
 

ROMANE
(2013-2017)
Bpifrance funds

Role of mast cell in neurology – Exploitation of an innovative therapeutic approach in Alzheimer’s disease. 
 

Coordination: AB Science (France).
 

APAS-IPK
(2009-2014)
Bpifrance funds

Improving the Predictivity of Activity and Selectivity of Protein Inhibitor Kinases in Oncology.
 

Coordination: AB Science (France).
 

CONCO
(2007-2012)
European/FP6 grants

Applied venomics of the cone snail species Conus consors for an accelerated, cheaper, safer and more ethical production of innovative biomedical drugs.

Coordination: Atheris (Switzerland)

SYSCO
(2007-2011)
European/FP6 grants

Systematic functional analysis of intracellular parasitism as a model of genomes conflict
Example of Leishmania.
 

Coordination: Biobase (Germany)

USDEP
(2006-2010)
European/FP6 grants

Capture and enrichment of emerging pathogens for multiple and ultra-sensitive diagnostics.
 

Coordination: Robert Koch Institute (Germany)

LEUKEMIA
(2003-2012)
PHRC grants

Study of cell differentiation genes in patients suffering from Acute Myeloid Leukemia, Chronic Myeloid Leukemia and Chronic Myeloid Monocytic Leukemia.

Coordination: Nimes hospital (France)